• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴细胞与 C 反应蛋白比值对接受胰腺癌手术切除患者的预后影响。

Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer.

机构信息

Department of Surgery, Saiseikai Fukuoka General Hospital, Japan.

Departments of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Japan.

出版信息

Am Surg. 2023 Nov;89(11):4452-4458. doi: 10.1177/00031348221117034. Epub 2022 Aug 3.

DOI:10.1177/00031348221117034
PMID:35920820
Abstract

BACKGROUND

Increasing evidence indicates that increased systemic inflammation is correlated with poorer cancer-specific survival in various cancer types. This study aimed to evaluate the prognostic value of various combinations of inflammatory factors in patients who underwent surgical resection for pancreatic cancer (PC).

METHODS

We retrospectively analyzed 97 consecutive patients with PC who underwent pancreatectomy. We assessed the predictive impact for recurrence using a combination of 5 inflammatory markers and focused on the lymphocyte-C-reactive protein ratio (LCR) to elucidate its prognostic and predictive value for recurrence-free survival (RFS) and overall survival (OS) in univariate and multivariate analyses using the Cox proportional hazards model.

RESULTS

Low preoperative LCR was correlated with low serum hemoglobin, low serum albumin concentration, high frequency of microscopic vascular invasion, and high frequency of microscopic perineural invasion. The low LCR group had significantly worse RFS and OS. Lower preoperative LCR was an independent predictor of shorter RFS and OS in this cohort.

DISCUSSION

Preoperative LCR is a novel and convenient prognostic marker for patients with PC. Patients with low LCR may require more favorable intensive therapy.

摘要

背景

越来越多的证据表明,全身炎症反应增加与多种癌症类型的癌症特异性生存率降低相关。本研究旨在评估接受胰腺癌(PC)手术切除的患者中各种炎症因子组合的预后价值。

方法

我们回顾性分析了 97 例接受胰腺切除术的 PC 连续患者。我们使用 5 种炎症标志物的组合评估了复发的预测影响,并重点关注淋巴细胞- C 反应蛋白比值(LCR),以使用 Cox 比例风险模型在单变量和多变量分析中阐明其对无复发生存(RFS)和总生存(OS)的预后和预测价值。

结果

低术前 LCR 与低血清血红蛋白、低血清白蛋白浓度、微血管侵犯频率高和微神经周围侵犯频率高相关。低 LCR 组的 RFS 和 OS 明显更差。在本队列中,较低的术前 LCR 是 RFS 和 OS 较短的独立预测因素。

讨论

术前 LCR 是 PC 患者的一种新颖且方便的预后标志物。LCR 较低的患者可能需要更有利的强化治疗。

相似文献

1
Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer.淋巴细胞与 C 反应蛋白比值对接受胰腺癌手术切除患者的预后影响。
Am Surg. 2023 Nov;89(11):4452-4458. doi: 10.1177/00031348221117034. Epub 2022 Aug 3.
2
Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.淋巴细胞与 C-反应蛋白比值作为肝细胞癌的预后因素。
Int J Clin Oncol. 2021 Oct;26(10):1890-1900. doi: 10.1007/s10147-021-01985-x. Epub 2021 Jul 12.
3
Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.淋巴细胞- C 反应蛋白比值作为预测结直肠癌手术和肿瘤学结局的有前途的新标志物。
Ann Surg. 2020 Aug;272(2):342-351. doi: 10.1097/SLA.0000000000003239.
4
Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.淋巴细胞与C反应蛋白比值及评分是胃癌患者临床可行的预后营养炎症标志物。
Clin Nutr. 2020 Apr;39(4):1209-1217. doi: 10.1016/j.clnu.2019.05.009. Epub 2019 May 21.
5
Prognostic Impact of Lymphocyte-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma.淋巴细胞与C反应蛋白比值对接受手术切除的肝细胞癌患者的预后影响
J Gastrointest Surg. 2022 Jan;26(1):104-112. doi: 10.1007/s11605-021-05085-z. Epub 2021 Jul 13.
6
Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.术前C反应蛋白与白蛋白比值是胰腺导管腺癌胰腺切除术后生存的预测指标。
Asia Pac J Clin Oncol. 2019 Oct;15(5):e109-e114. doi: 10.1111/ajco.13123. Epub 2019 Jan 10.
7
Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study.淋巴细胞与 C 反应蛋白比值预测结直肠癌肝转移患者肝切除术后预后:一项回顾性研究。
Anticancer Res. 2022 Oct;42(10):4963-4971. doi: 10.21873/anticanres.16003.
8
Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer.淋巴细胞与 C 反应蛋白比值可更好地预测 IV 期癌症患者的预后。
BMC Cancer. 2022 Oct 20;22(1):1080. doi: 10.1186/s12885-022-10145-x.
9
Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8 tumor-infiltrating lymphocytes as a predictor of prognosis after resection of intrahepatic cholangiocarcinoma.术前淋巴细胞/ C-反应蛋白比值及其与 CD8 肿瘤浸润淋巴细胞的相关性可作为预测肝内胆管细胞癌切除术后预后的指标。
Surg Today. 2021 Dec;51(12):1985-1995. doi: 10.1007/s00595-021-02295-5. Epub 2021 May 19.
10
Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.淋巴细胞与 C 反应蛋白比值对预测食管胃结合部癌患者生存及术后并发症的临床价值。
Surg Oncol. 2022 Sep;44:101842. doi: 10.1016/j.suronc.2022.101842. Epub 2022 Aug 30.

引用本文的文献

1
The role of lymphocyte-C-reactive protein ratio in the prognosis of gastrointestinal cancer: a systematic review and meta-analysis.淋巴细胞与C反应蛋白比值在胃肠道癌预后中的作用:一项系统评价和荟萃分析
Front Oncol. 2024 Aug 29;14:1407306. doi: 10.3389/fonc.2024.1407306. eCollection 2024.
2
Lymphocyte-to-C-Reactive Protein (LCR) Ratio Is Not Accurate to Predict Severity and Mortality in Patients with COVID-19 Admitted to the ED.淋巴细胞与 C 反应蛋白(LCR)比值不能准确预测急诊科收治的 COVID-19 患者的严重程度和死亡率。
Int J Mol Sci. 2023 Mar 22;24(6):5996. doi: 10.3390/ijms24065996.
3
Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options.
临床诊断和胰腺癌的治疗管理:标志物、分子机制和治疗选择。
World J Gastroenterol. 2022 Dec 28;28(48):6827-6845. doi: 10.3748/wjg.v28.i48.6827.